FIGURE

Fig. 3

ID

ZDB-FIG-240411-21

Publication

Liu et al., 2024 - Targeting CD38/cyclic ADP-ribosyl cyclase as a novel therapeutic strategy for identification of three potent agonists for leukopenia treatment

Other Figures

All Figure Page

Back to All Figure Page

Fig. 3

The activity of ADP ribosyl cyclase is implicated in myeloid differentiation and bactericidal activity induced by ZGSII, BA, and DMA. (A) Effects of ZGSⅡ (10 μM), BA (10 μM), DMA (10 μM), or C3G (40 μM) on CD11b expression after 5 days of treatments. (B) The histogram shows the percentage of CD11b+ cells for each group. (C) Giemsa-Wright staining of NB4 cells treated with ZGSⅡ, DMA, BA, or C3G for 5 days. Yellow arrows represent differentiated NB4 cells. Bars = 10 µm. (D) Bactericidal activity evaluation. The cells were treated with ZGSⅡ, BA, DMA, or C3G for 5 days, followed by a bacterial killing assay. (E, F) The histograms display the percentage of differentiated NB4 cells (E) and the number of killed bacteria (F) for each group. The data are presented as the mean ± SD of three independent experiments. *p < 0.05; * *p < 0.01; * **p < 0.001 versus the corresponding control groups (one-way analysis of variance).

Expression Data

Expression Detail

Antibody Labeling

Phenotype Data

Phenotype Detail

Acknowledgments

This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ Pharmacol. Res.